The metastatic breast cancer information center (MBCInfoCenter℠) provides helpful resources and support for those afflicted with metastatic breast cancer.
Metastatic breast cancer is also classified as Stage 4 breast cancer. The cancer has spread to other parts of the body. This usually includes the lungs, liver, bones or brain.
Being diagnosed with recurrent or metastatic breast cancer can be overwhelming. Women experiencing a recurrence may find themselves back on the emotional rollercoaster they thought they got off of after initial treatment.
Xeloda is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Xeloda is classified as an "antimetabolite." (For more detail, see "How Xeloda Works" section below).
Abemaciclib is showing promise for heavily pretreated patients with refractory, hormone-receptor (HR)–positive, HER2-negative advanced breast cancer when used as a single agent, according to phase 2 findings of the MONARCH 1 trial.
Celldex is taking multiple shots on goal with immune-modulating candidate varlilumab in combination with the incredibly successful Opdivo from Bristol-Myers Squibb and recently approved Tecentriq from Roche.
The lack of older patients in clinical trials has led to major "gaps in knowledge regarding outcomes and toxicity in this ever-expanding group of cancer patients," notes a letter to the editor published online July 18 in the Journal of Clinical Oncology.
A team of researchers take a retrospective look at the patterns of how, when, and to whom palliative options are presented to patients with metastatic breast cancer, as an approach for gaining insight on how to improve care for patients with late-stage, terminal cancers.
Survival was equal for patients with stable and unstable SBM. However, prognostic factors differed in both groups and stability should therefore be considered in treatment decision-making.
By developing a new mathematical model, Neznanov and Tyuryumina aimed to improve cancer growth prediction.
When patients were asked about the aims of breast cancer follow-up, they most frequently mentioned that follow-up was to detect recurrence or give reassurance
Long-time LBBC volunteer Caryn Kaplan reflects on what’s she’s lost and gained from her initial diagnosis to a re-diagnosis of metastatic breast cancer.Join Caryn in our Beyond The Brea…
Laura Snyder, on making treatment decisions and the importance of clear communication in care for metastatic breast cancer. Learn more about metastatic disease from our campaign, Beyond the Breast.…
Our Vision: A world where no one impacted by breast cancer feels uninformed or alone. Our Mission: To connect people impacted by breast cancer to trusted information and a community of support. Liv…
